Lessee, Operating Lease, Liability, Undiscounted Excess Amount of IDEXX LABORATORIES INC /DE from 31 Mar 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
IDEXX LABORATORIES INC /DE quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD history and change rate from 31 Mar 2019 to 31 Dec 2025.
  • IDEXX LABORATORIES INC /DE Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending 31 Dec 2025 was $19,233,000, a 6.9% decline year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Change (%)

IDEXX LABORATORIES INC /DE Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $19,233,000 -$1,426,000 -6.9% 31 Dec 2025 10-K 20 Feb 2026 2025 FY
Q3 2025 $20,348,000 -$2,054,000 -9.2% 30 Sep 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 $21,619,000 -$262,000 -1.2% 30 Jun 2025 10-Q 04 Aug 2025 2025 Q2
Q1 2025 $20,220,000 -$1,965,000 -8.9% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $20,659,000 -$424,000 -2% 31 Dec 2024 10-K 21 Feb 2025 2024 FY
Q3 2024 $22,402,000 +$648,000 +3% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $21,881,000 +$311,000 +1.4% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $22,185,000 +$897,000 +4.2% 31 Mar 2024 10-Q 01 May 2024 2024 Q1
Q4 2023 $21,083,000 +$90,000 +0.43% 31 Dec 2023 10-K 22 Feb 2024 2023 FY
Q3 2023 $21,754,000 +$3,875,000 +22% 30 Sep 2023 10-Q 01 Nov 2023 2023 Q3
Q2 2023 $21,570,000 +$3,008,000 +16% 30 Jun 2023 10-Q 01 Aug 2023 2023 Q2
Q1 2023 $21,288,000 +$7,617,000 +56% 31 Mar 2023 10-Q 02 May 2023 2023 Q1
Q4 2022 $20,993,000 +$6,095,000 +41% 31 Dec 2022 10-K 16 Feb 2023 2022 FY
Q3 2022 $17,879,000 +$2,515,000 +16% 30 Sep 2022 10-Q 01 Nov 2022 2022 Q3
Q2 2022 $18,562,000 +$2,279,000 +14% 30 Jun 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 $13,671,000 -$1,279,000 -8.6% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $14,898,000 +$66,000 +0.44% 31 Dec 2021 10-K 16 Feb 2022 2021 FY
Q3 2021 $15,364,000 +$640,000 +4.3% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 $16,283,000 +$7,000 +0.04% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 $14,950,000 -$572,000 -3.7% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 $14,832,000 -$1,440,000 -8.8% 31 Dec 2020 10-K 12 Feb 2021 2020 FY
Q3 2020 $14,724,000 -$2,480,000 -14% 30 Sep 2020 10-Q 29 Oct 2020 2020 Q3
Q2 2020 $16,276,000 -$1,809,000 -10% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $15,522,000 -$2,736,000 -15% 31 Mar 2020 10-Q 30 Apr 2020 2020 Q1
Q4 2019 $16,272,000 31 Dec 2019 10-K 14 Feb 2020 2019 FY
Q3 2019 $17,204,000 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 $18,085,000 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $18,258,000 31 Mar 2019 10-Q 01 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.